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Background: P21 is one kind of cyclin-dependent kinase inhibitor that can prevent cells from going through the
G1/S phase checkpoint and inhibit cell proliferation. Proliferative vitreoretinopathy (PVR) is a proliferative response in
the eye. The aim of this study was to determine whether p21Waf1/Cip1 (p21) suppresses the proliferation and
migration of retinal pigment epithelial (RPE) cells in vitro and controls PVR development in vivo.
Methods: Cell cycle analyses and transwell assays were conducted to assess cell proliferation characteristics and the
migration ability of RPE cells after transfection with p21. Western blot and reverse-transcription polymerase chain
reaction technologies were used to detect the expression of p21, CDK2 and cyclinE in RPE cells and rabbit retinal
tissues. The impact of increasing p21 expression on PVR development was conducted by implantation of an
adenovirus vector containing rabbit p21 (rAd-p21) in a PVR rabbit model. The prevalence of PVR and retinal detachment
was determined by indirect ophthalmoscopy on days 3, 7, 14, and 21 after the injection of rAd-p21 into the vitreous.
B scans and hematoxylin-eosin staining were employed to check rabbit retinas on day 21.
Results: Cell cycle analyses and transwell assays showed that p21 inhibited the proliferation and migration of RPE cells.
Increased expression of p21 was detected in cultured RPE cells and rabbit retinas after transfection with the p21 gene,
whereas levels of CDK2 and cyclinE were decreased. The increase in p21 expression effectively suppressed the
development of PVR in a rabbit model.
Conclusions: The increase in p21 expression in RPE cells not only inhibits the proliferation and migration of RPE cells
in vitro, but also suppresses the development of PVR in vivo, which indicates its therapeutic potential in treating PVR.
Keywords: P21Waf1/Cip1, Cell cycle arrest, Retinal pigment epithelial cells, Proliferative vitreoretinopathyBackground
Proliferative vitreoretinopathy (PVR) is characterized by
the migration and proliferation of cells following a break
in the retina or trauma, leading to formation of periretinal
membranes, followed by contraction of cellular membranes
and traction on the retina that causes retinal detachment.
The retinal pigment epithelium (RPE) is a critical cell layer
that undergoes proliferation in PVR. In PVR, the RPE cells* Correspondence: phuayan2000@163.com
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unless otherwise stated.come into the vitreous and migrate to the vitreoretinal
interface, where they proliferate and form traction epiret-
inal membranes. Effective treatment of PVR remains as a
clinical challenge in ophthalmology. Although modern
vitreoretinal microsurgery has obtained satisfactory results
in the treatment of PVR, operational complications and/
or poor visual acuity have been associated outcomes in
many cases [1,2]. Therefore, it is important to obtain a
better understanding of the pathogenesis of this disease
and to find new strategies for the prevention and treat-
ment of PVR.
The p21 protein belongs to the family of cyclin-
dependent kinase inhibitors (CDKIs), which play antd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sion [3]. In cells, p21 forms quaternary complexes with
cyclins, CDKs, and proliferating cell nuclear Ag, which
are essential for cell cycle progression. Up-regulation
of p21 expression and other CDKIs results in activa-
tion of suppression molecules of CDKs and cyclinE,
allowing accumulation of hypophosphorylated Rb and
cell cycle arrest in the G1 phase [4,5]. On the contrary,
decreased expression of p21 is associated with several
proliferative diseases in the eye, such as pterygium and
retinoblastoma [6,7]. A previous study has shown that
an increase in p21 by subconjunctival injection of the
recombinant adenovirus vector-mediated p21 gene in-
hibits fibroproliferation and wound healing in a rabbit
model of glaucoma filtration surgery [8].
Previous studies have suggested a role for p21 in
tumorigenesis [9,10]; however, its function in PVR has
not been reported. In this study, we characterized the
function of p21 in the proliferation and migration of
RPE cells, and explored its possible role in experimental
PVR. Our findings indicated that p21 might play a pro-
tective role in PVR and may be a new target for PVR
treatment.Methods
Reagents
The recombinant adenovirus vector-mediated p21 gene
(rAd-p21) and recombinant adenovirus empty vector
(rAd-NC) were obtained from GeneChem Co. Ltd.
(Shanghai, China). Human RPE cells (D407 cell line) were
purchased from Chuan Xiang Biological Technology Co.
Ltd (Shanghai, China). Platelet rich plasma (PRP) was
isolated from the peripheral blood of healthy people. The
study was approved by Tianjin Medical University General
Hospital Medical Ethics Committee (201315). Written in-
formed consent for blood sampling was obtained from all
participants according to the Declaration of Helsinki. After
centrifuging for 10 min (1500 rpm/min at 4°C), 25 ml of
PRP containing platelets of 4.00 × 108/ml was obtained.Cell culture and recombinant adenovirus vector-mediated
p21 gene transfection
Human RPE cells (D407 cell line) were cultured in 1640
medium with 10% fetal bovine serum (FBS; Hyclone,
USA), 100 U/mL penicillin, and 100 μg/mL streptomycin
at 37°C in an atmosphere of 5% CO2. Before transfection,
cells were starved in serum-free medium for 24 hours.
Quiescent cells were plated in six-well plates and divided
into a phosphate-balanced solution (PBS) group, rAd-p21
transfection group and negative control group (rAd-NC
group), and then were incubated overnight with PBS, rAd-
p21 and rAd-NC, respectively. After 24 hours, the cells
were washed and cultured with complete medium.Cell cycle analysis by flow cytometry
Human RPE cells (1 × 106) in six-well plates were incu-
bated with PBS, rAd-p21 and rAd-NC transfection re-
agents for 24 hours. The cells were harvested and fixed in
70% ethanol. Before analysis, cells were washed with PBS
and resuspended in PBS (pH = 7.4). RNase (100 μg/ml)
and propidium iodide (50 μg/ml) were added to suspend
the cells for 30 min. The use of a Becton-Dickenson
FACSVantage flow cytometer system (Becton-Dickenson,
USA) determined the DNA histograms, and Cell Quest
software version 3.2 (Becton-Dickenson, USA) was used
to analyze the cell cycle distribution. The experiments
were performed in triplicate and repeated three times.
Transwell assay
Corning Transwell 3422 Chambers (Corning, USA) were
used to assess human RPE cell migration in response to
the p21 gene. After 24 hours transfection, each group of
cells (incubated with PBS, rAd-p21 or rAd-NC) was har-
vested and reseeded at a density of 2.5 × 104 per well in
the upper chamber with 8 μm membranes in serum-free
1640 medium. The 1640 medium containing 10% FBS
was placed in the lower chamber. After 6 hours, non-
migrating RPE cells were gently scrubbed and removed
from the surface. Migrating cells attached to the mem-
brane were fixed with 1% glutaraldehyde and stained
with 0.1% crystal violet. To assess the average number of
migrating cells, cells were counted in five random high
power fields. All experiments were repeated three times.
Western blot analysis
The cold radio-immunoprecipitation assay (RIPA) buffer
and phenylmethylsulfonyl fluoride (PMSF; a protease
inhibitor) were used to prepare the cells, which were
washed twice with ice-cold PBS. A cell scraper was used
to gather cell lysates, which were collected and transferred
to a microcentrifuge tube and centrifuged for 15 minutes
at 12,000 × g (4°C). The supernatant was collected and a
BCA protein assay kit (Pierce, Rockford, USA) was used
to measure the protein content of each lysate. Electro-
phoresis was performed (25 ug protein/well) with the use
of a sodium dodecyl sulfate polyacrylamide gel electrophor-
esis gel, which was then transferred to a polyvinylidene
difluoride membrane and analyzed by immunoblotting.
The primary anti-p21 polyclonal antibody (1:200; Santa
Cruz, California, USA), CDK2 polyclonal antibody (1:500;
Santa Cruz, California, USA), cyclinE polyclonal antibody
(1:500; Santa Cruz, California, USA) and antibody against
β-actin (1:2000; Millipore, Massachusetts, USA) were used
to immunodetect p21, CDK2, cyclinE and β-actin, respect-
ively. Band densities of the p21, CDK2 and cyclinE pro-
teins were all normalized to β-actin and quantified by
ImageJ software. Western blot analyses were repeated
three times.
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reaction
According to the manufacturer’s instructions, TRIzol re-
agent (Invitrogen, Carlsbad, CA) was used to isolate total
RNA from the RPE. Samples of RNA (about 1 μg to
2 μg of total RNA) were reverse-transcribed to cDNA
with gene-specific primers using the TransScript RT-
PCR System kit (Transgen, Beijing, China). The target
gene single-stranded cDNA was amplified in a polymer-
ase chain reaction (PCR), with sequence-specific primers
of p21 (forward primer: 5′-CCT TGT CCT TTC CCT
TCA-3′, reverse primer: 5′-TCC TTG TTC CGC TGC
TAA-3′, 355 bp), of CDK2 (forward primer: 5′-ATC
CGC CTG GAC ACT GAG-3′; reverse primer: 5′-GTG
GAG GAC CCG ATG AGA-3′; 273 bp), of cyclinE (for-
ward primer: 5′-TTC CAC ACA GGA GCA AAG TAT
G-3′; reverse primer: 5′-TGC AAC TTT GGA GGG
TAG ATT T-3′; 377 bp), and of β-actin (forward primer:
5′-AGT TGC GTT ACA CCC TTT C-3′; reverse pri-
mer: 5′-CAC CTT CAC CGT TCC AGT-3′, 147 bp).
Expression of β-actin was used as the internal standard.
Amplification was performed in a thermal cycler at 94°C
for 30 s, at 56°C for 30 s, and at 72°C for 30 s over 35
cycles. Reverse-transcription (RT)-PCR products were
electrophoresed on a 1.5% agarose gel and visualized with
ethidium bromide. The intensities of the amplified cDNA
fragments were estimated with a video-densitometer.
Animals and induction of PVR
Thirty adult pigmented rabbits (2.0–2.5 kg) were pur-
chased from the Beijing Shahe Tongli Experimental
Animal Farm (Beijing, China). All animal experiments
conformed to the protocols approved by the Animal
Care and Use Committee of Tianjin Medical University
(TMUaMEC2013008). All of the rabbits were anesthe-
tized with an intramuscular injection of ketamine
(50 mg/kg) and promethazine (25 mg/kg). Before the
surgery, rabbit pupils were dilated with tropicamide and
the rabbits were given antibiotics. PVR was induced by
intravitreal injection of 2.5 × 105 human RPE cells in
0.1 mL PRP with a 30-gauge needle. An anterior chamber
paracentesis was made and approximately 0.1 mL aqueous
humor was drained with a 30-gauge needle before the
injection.
Intravitreal injection of rAd-p21
All the rabbits were randomly divided into 3 groups ran-
domly 7 days after PVR was induced: PBS group (n = 10,
intravitreal injection of 3 μL PBS); empty vector group
(n = 10, intravitreal injection of 3 μL rAd-NC); and gene
treated group (n = 10, intravitreal injection of 3 μL rAd-
p21). Guided by an operating microscope, rAd-p21,
rAd-NC or PBS was injected into the superotemporal
area posterior to the lens using a metal needle connectedto a glass syringe (Hamilton Co., Reno, NV), taking care
to avoid penetration of the lens or damage to the vortex
veins. The injection site was 3 mm posterior to the super-
otemporal limbus. The injection site was visualized with a
standard indirect ophthalmoscope and a 90-Dcondensing
lens (Volk Optical Inc., Mentor, OH) after each injection.
The fundus status of each rabbit was acquired on days 3,
7, 14 and 21. The findings were grouped into six stages
according to Fastenberg et al. [11]; i.e., stage 0, no lesions;
stage 1, intravitreal membranes; stage 2, retinal focal trac-
tion; stage 3, focal retinal detachment involving less than
two quadrants; stage 4, extensive retinal detachment in-
volving more than two quadrants; and stage 5, total retinal
detachment, folds, and holes. All rabbits were anesthetized
and examined with a B scan to access PVR and retinal
detachment, and then they were sacrificed at the end of
the experiments by anesthetic overdose.Hematoxylin-eosin staining
The eyes were enucleated and imbedded in 10% formalin
for 2 days, and then imbedded in paraffin blocks, which
were then cut into 5 μm thick slices and stained with
hematoxylin-eosin (H&E). The slices were photographed
with a digital camera after dehydration and fixation.Western blot analysis and reverse transcription
polymerase chain reaction in vivo
The eyes were enucleated and the retinas were dissected
and isolated from the RPE. The retinas were analyzed by
western blot and were lysed directly on ice in 300 uL
RIPA buffer and PMSF. The lysed retinas were centri-
fuged and the supernatants were transferred to new
tubes, and then the supernatants were processed as de-
scribed previously. The RT-PCR analysis of retinas was
performed as described previously.Statistics
The data were analyzed with a one way analysis of variance
and χ2 analysis. A value of p < 0.05 was considered to be
statistically significant.Results
Overexpression of p21 inhibits the cell cycle in human
PRE cells
We overexpressed p21 by transfection of rAd-p21. Sub-
sequently, to determine whether p21 inhibits the prolifera-
tion of RPE cells, we performed flow cytometry to analyze
the cell cycle progression. As shown in Figure 1, rAd-p21
induced G0/G1 phase cell cycle arrest compared with the
PBS and rAd-NC groups. This result suggested that up-
regulation of p21 could inhibit the proliferation of human
RPE cells.
Figure 1 Effect of the p21 gene on the cell cycle of cultured human RPE cells. A: RPE PBS, B: RPE rAd-NC, C: RPE rAd-p21, D: Bar graph
represents the quantitative data of RPE cell cycle distribution in PBS, rAd-NC and rAd-p21 groups. Each value represents the mean ± SD of three
independent experiments, each performed in triplicate (*P < 0.05).
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cells
To examine the effect of p21 on the migration of human
RPE cells, Transwell assays were performed in the PBS,
rAd-NC and rAd-p21 groups. As shown in Figure 2,
rAd-p21 suppressed human RPE cell migration com-
pared with the PBS and rAd-NC groups in vitro. This
result demonstrated that overexpression of p21 inhibited
the migration of human RPE cells.
Overexpression of p21 inhibits levels of CDK2 and CyclinE
in vitro and in vivo
To further confirm the function of p21, we transfected
rAd-p21 into cultured human RPE cells, which showed
that p21 expression in RPE cells was significantly in-
creased at both protein and mRNA levels in the rAd-p21
group compared with the PBS and rAd-NC groups.
Meanwhile, expression of CDK2 and cyclinE was de-
pressed in the rAd-p21 group compared with the PBS
and rAd-NC groups (Figure 3). These results suggested
that overexpression of p21 suppressed the expression of
CDK2 and cyclin E in vitro.To investigate the potential role of the p21 gene for
cell cycle regulatory proteins in the inhibition of experi-
mental PVR, we examined retinal protein and mRNA
levels of p21, CDK2 and cyclinE after injecting rAd-p21
into the vitreous. Western blot and RT-PCR analysis of
total retinal lysates indicated that p21 expression was
significantly increased both at the protein and mRNA
levels in the gene treated group compared with the PBS
and empty vector groups, whereas expression of CDK2
and cyclinE were suppressed in the rAd-p21 treated
group compared with the PBS and empty vector groups
(Figure 4). The results were consistent with the experi-
ment in vitro. This result showed that rAd-p21 could act
on the retina and overexpress the protein p21.
Effect of rAd-p21 on the inhibition of experimental PVR
In all groups, we found that the stage of PVR progressed
steadily over time by examination with indirect ophthal-
moscopy. Proliferative membranes were formed without
retinal detachment in the rabbit eyes in all groups on
the 3rd day after injection. There were massive prolifera-
tive membranes on the surface of the retina with focal
Figure 2 Effect of the p21 gene on the migration of cultured human RPE cells. A: RPE PBS, B RPE rAd-NC, C: RPE rAd-p21, D: Bar graphs represent
the number of migrating RPE cells in PBS, rAd-NC and rAd-p21 groups. Each value represents the mean ± SD of three independent experiments, each
performed in triplicate (*P < 0.05).
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on the 7th day after injection; however, there were fewer
proliferative membranes with or without retinal detach-
ment in the gene treated group than the control groups.
Then tractional retinal detachment developed in the
posterior retina on the 14th day and in the peripheral
retina with total retinal detachment on the 21st day in
the control groups. However, eyes with retinal detach-
ment in the gene treated group on the 14th day were less
prevalent than in the control group, and there was noFigure 3 Protein and mRNA levels of p21, CDK2 and cyclinE in human R
respectively. A: Expressions of P21, CDK2 and cyclinE were assessed by we
used as the control. B: Expression of p21, CDK2 and cyclinE mRNA were ass
mRNA by densitometric scan. (n = 6). The error bars represent the standard
and cyclinE protein and mRNA levels in the rAd-p21 group compared withtotal retinal detachment on the 21st day. The stages of
groups according to Fastenberg on the 21st day after
treatment are shown in Table 1. The eyes in stage 4 and
stage 5 were thought to have retinal detachments. The
results showed that there were statistically significant
differences in the rAd-p21 group compared with the other
two groups on the 21st day after treatment (Figure 5). B
scans and H&E staining of rabbit retinas on the 21st
day showed proliferative membranes with severe ret-
inal detachment in the PBS and empty vector groups.PE cells was examined by western blotting and RT-PCR analysis,
stern blot analysis in PBS, rAd-NC and rAd-p21 groups. β-Actin was
essed by RT-PCR analysis. C, D: Quantitative analysis of proteins and
deviation. There were statistically significant differences in p21, CDK2
the other two groups. (*p < 0.05).
Figure 4 Retinal expression of p21, CDK2 and cyclinE protein and mRNA levels after treatment analyzed by western blotting and
RT-PCR assays, respectively. A: Expression of P21, CDK2 and cyclinE were assessed by western blot analysis in PBS, rAd-NC and rAd-p21 groups
in vivo. B: Expressions of p21, CDK2 and CyclinE mRNA were assessed by RT-PCR analysis in the three groups in vivo. C, D: Quantitative analysis of
proteins and mRNA by densitometric scans (n = 6). The columns are the mean ± SD of three independent groups. There were statistically
significant differences in p21, CDK2 and cyclinE protein and mRNA levels in the p21 gene treated group in vivo compared with the other
two groups (*p < 0.05).
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proliferative membranes without severe retinal detach-
ment. This result indicated that overexpression of p21
inhibited PVR progression (Figure 6).
Discussion
PVR is a vision-threatening disease and a common com-
plication after surgery to correct rhegmatogenous ret-
inal detachment. PVR is a proliferative response within
the eye. Its pathological processes include inflammatory
cell infiltration, proliferation of cell growth and the for-
mation of scars. Other studies have demonstrated that
fibrocellular membranes in PVR mainly consist of RPE
cells, macrophages, glial cells, periostin and fibroblast-
like cells [12,13]. Injection of those cells into the vitre-
ous in animal models, whether they are macrophages,
fibroblasts or RPE cells, results in pathology that mimics
PVR [14,15]. During the course of PVR formation, the
proliferation and migration of RPE cells is a very im-
portant step. RPE cells move from under the photo-
receptor layer into the vitreous cavity and stay on theTable 1 Stages of groups according to Fastenberg on the
21st day after treatment
Stage PBS group rAd-NC group rAd-p21 group
0 0 0 0
1 0 0 1
2 0 0 1
3 1 1 5
4 4 3 3
5 5 6 0retinal surface to form an epiretinal membrane. However,
some studies have already shown that RPE cells are very
poor inducers of PVR alone when injected in a rabbit eye.
Therefore, we chose to use RPE cells in an in vitro experi-
ment and RPE cells and PRP to induce PVR in an animal
model.
P21 is known as an important CDKI with a wide range
of kinase inhibition activity, which can effectively inhibit
CDK2 and cyclins to prevent cells from going through
the G1/S phase checkpoint, and to inhibit cell prolifera-
tion [16,17]. Previous studies have shown that p21 sup-
pressed tumor cell migration and proliferation [9,10]. PVRFigure 5 Number of eyes with retinal detachment (RD). There
were statistically significant differences in the number of eyes with
RD in the rAd-p21 group in vivo compared with the other two groups
on the 21st day after treatment (*p < 0.05).
Figure 6 B scans and H&E staining (B scan, A-C; H&E staining, D-F, 200×). The retinas of rabbits at 21 days after treatment revealed that
rAd-p21 significantly inhibited PVR. B scans showed significantly proliferative membranes with severe retinal detachment in the PBS and rAd-NC
groups (A,B). However, rAd-p21 treatment inhibited proliferative membranes without severe retinal detachment. (C) H&E staining indicated that
retinal microanatomy had more integrity in the rAd-p21 group (F) than in groups PBS and rAd-NC (D,E).
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cycle blocking agents are commonly used in the treat-
ment of PVR [18,19]. Furthermore, p21 showed low
expression levels in PRE-19 cells delivered from human
RPE cells, which are important in the pathogenesis of
PVR [20]. However, there have been no reports of p21
gene therapy in PVR. Finally, our study indicated that
p21 has a role in the suppression of PRE cell prolifera-
tion and migration in vitro, and inhibits PVR in vivo.
Adenovirus-mediated gene transfection technology has
been widely applied in research on ophthalmic diseases
[21-23]. For example, clinical trials have indicated that
adenovirus vectors containing wild type p53 was a safe,
feasible gene-therapy approach [24]. In our study, p21
was successfully transfected into the human D407 RPE
cell line by an adenovirus vector in vitro, and the protein
and gene of p21 showed significantly higher expression
in the rAd-p21 group compared with the rAd-NC group.
Up-regulation of p21 arrested the cell cycle at the G1
phase, and the number of cells in the G0 and G1 phases
was significantly increased. P21 belongs to the Cip/Kip
family, which is one of the CDKIs, and can block the ac-
tivity of cyclin/CDK complexes, specifically CDK2 in E/A-
CDK2 cyclin complexes [3]. These complexes block the
cell-cycle transition from the G1 phase to the S phase.
P21 is regulated by two different pathways, i.e., a p53-
dependent pathway (DNA damage leading to the activa-
tion of p53 and upregulation of p21 causing cell cycle
blockage in the G1 phase with possible DNA repair or
induction of apoptosis), and a p53-independent pathway
(through cell growth factors, such as interferon-β and
tumor necrosis factor-α, which are able to induce p21 inp53-deficient cells in quiescence) [25,26]. Our results
also indicated that p21 overexpression was connected
with the depression of CDK2 and cyclinE in human RPE
cells, leading to arrest of the cell cycle and reduction of
the proliferation of cells.
Cell migration is another important process in the de-
velopment of PVR. Without migration, RPE cells would
not be involved in the formation of a proliferative epiret-
inal membrane by entering the vitreous cavity and
settling down on the surface of the retina. In this study,
p21 overexpression inhibited the migration of RPE cells,
which is consistent with its effects on the migration of
vascular smooth muscle cells (SMCs), epithelial cells and
cancer cells [27-30]. Previous studies have reported that
the migration of RPE cells depended on the PI3K/AKT
and MAPK signaling pathways, and p21 inducing cell
cycle progression and survival also depended on PI3K/
AKT and MAPK activations [31-33]. Therefore, the poten-
tial mechanism of p21 depressing RPE cell migration prob-
ably depends on PI3K/AKT and MAPK signaling pathways.
The results will be verified by further experiments.
Experimental models of PVR were conducted to investi-
gate intraocular proliferation. Intraocular injection of RPE
cells and PRP to establish a PVR animal model is one of
the commonly used methods that can induce intravitreal
proliferative responses. The response will reach a peak for
nearly 2 weeks and develop tractional retinal detachment
at 3–4 weeks after injection [34]. Furthermore, we have
previously shown that the expression of p21 decreased
gradually from 7 days and reached the lowest point at
2 weeks after PVR induction. The expression of p21 and
PVR development has a negative correlation. In agreement
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vitreal injection 7 days after PVR induction. Increased
mRNA and protein expression of p21 in vivo by western
blotting and RT-PCR indicated that rAd-p21 could in-
corporate within the retina. The development of a prolif-
erative membrane and retinal detachment, shown by B
scans and HE staining, in the gene treated group was
lighter than in the control groups. Western blot and RT-
PCR showed that the expression of p21 was up-regulated,
whereas the expression of CDK2 and cyclinE were down-
regulated after treatment. These results were consistent
with the results in vitro. Our study indicated that treat-
ment with p21 not only inhibited human RPE cell prolifer-
ation and migration in vitro but also probably arrested the
RPE cells in the G1 phase by regulating CDK2 and cyclinE
activity to inhibit the formation of proliferative mem-
branes and slowed down PVR development procession in
the rabbit PVR model. The signal pathway of p21 inhib-
ited PVR is still not clear. Previous studies reported that
the regulation of p21 was controlled at the transcriptional
level by both p53 dependent and independent mecha-
nisms [35]. The relationship between p21 and p53 was
mainly studied in tumors, and is perhaps similar in PVR.
During the treatment in vivo, all rabbits tolerated the
treatment well and there was no increase in systemic
toxicity. In addition, there was no cataract, glaucoma, or
endophthalmitis found by slit lamp and indirect ophthal-
moscopy during the treatment.
As is known, although RPE cells are main cells that
participate in epiretinal membrane formation, macro-
phages and fibroblasts also play key roles in this progres-
sion. Further research is necessary to determine whether
increased expression of p21 suppresses PVR in those
cells.
Conclusions
Our results suggested a role for the p21 gene in the in-
hibition of the proliferation and migration of PRE cells
in vitro, and showed the p21 gene can reduce the oc-
currence of severe PVR cases through inhibition the
expression of CDK2 and cyclin E. P21 gene may be a
new therapeutic target for PVR.
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